Zydus Lifesciences Buyback Latest News Today

Zydus Lifesciences Buyback Detail
Buyback Record Date Jun 2, 2022
Buyback Open Date Jun 23, 2022
Buyback Closing Date Jul 6, 2022
Issue Size (Shares) 1.15 Crores
Issue Size (Amount) ₹750.00 Crores
Buyback Price ₹650 per Share
  1. Zydus acquires rights from Pharmacosmos to market MonoFerric in India, Nepal to treat iron deficiency

    Sep 12, 2022 2:45:00 PM

    Zydus Lifesciences Ltd., an innovation-driven global lifesciences announced that it has acquired rights to market MonoFerric (iron isomaltoside) injections in India and Nepal from Denmark based ...

    Publish by : Pharmabiz
  2. Zydus Lifesciences acquire rights to market MonoFerric injections in India and Nepal

    Sep 9, 2022 6:20:00 PM

    Zydus is a market leader in the Nephrology area, with products including Oxemia, Zyrop, Renocrit, Kbind, Grafalon, Tacromus, and Mycomune. Zydus Lifesciences Ltd., a worldwide life sciences ...

    Publish by : India Infoline
  3. Zydus acquires rights to market MonoFerric from Pharmacosmos A/S of Denmark

    Sep 9, 2022 12:48:00 PM

    Zydus Lifesciences on Friday announced that it has entered into in-licensing agreement with Danish player Pharmacosmos A/S to market MonoFerric, or iron isomaltoside injections, in India and Nepal ...

    Publish by : Business Line
  4. Zydus Lifesciences launches cancer drug Lenalidomide in US

    Sep 20, 2022 2:00:00 PM

    Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells. Cancer is a large group of diseases that can start in almost any organ or tissue of ...

    Publish by : Daily
  5. Zydus gets USFDA nod for anti-cancer drug

    Sep 17, 2022 6:00:00 PM

    Zydus Lifesciences has received the approval of the United States Food and Drug Administration (USFDA) to market Lenalidomide, a cancer drug, the pharma firm told stock exchanges. The company ...

    Publish by : MSN
  6. Zydus Lifesciences bags USFDA final approval for Cariprazine Capsules; stock adds ~1%

    Sep 12, 2022 2:18:00 PM

    Zydus was among the first ANDA applicants to file a substantially complete ANDA with a paragraph IV certification for Cariprazine Capsules. The United States Food and Drug Administration (USFDA ...

    Publish by : India Infoline
  7. Zydus gets final USFDA nod for two drugs

    Aug 31, 2022 3:50:00 PM

    AHMEDABAD: Zydus Lifesciences Limited on Wednesday announced it has received final approval from the United States Food and Drug Administration (USFDA) for two drugs – Venlafaxine extended ...

    Publish by : MSN
  8. T-Mobile: Here Comes the Monster Buyback

    Sep 11, 2022 11:15:00 AM

    T-Mobile announced a $14 billion buyback on Thursday. It's an early start on a $60 billion plan that was supposed to start next year. The early start shows T-Mobile is ahead of plans on its Sprint ...

    Publish by : The Motley Fool
  9. Zydus Lifesciences US arm gets tentative USFDA approval for Sugammadex generic injection

    Sep 16, 2022 5:01:00 PM

    New Delhi, Sep 16 (PTI) Zydus Lifesciences Ltd on Friday said its US-arm has received tentative approval from the country's health regulator to market its generic version of Sugammadex injection.

    Publish by : Indiatimes
  10. T-Mobile’s Stock Buyback Is Here. It’s Just the Beginning.

    Sep 9, 2022 12:44:00 PM

    T-Mobile US announced a $14 billion share repurchase program on Thursday evening, the start of a process that could retire some two-thirds of the stock’s free float by the end of 2025.

    Publish by : Barron's

Read Zydus Lifesciences Buyback current news. Find Zydus Lifesciences Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Zydus Lifesciences Limited Buyback grey market premium and Zydus Lifesciences Buyback expected listing price.